Supplementary Tables S1-S7

<b>Supplementary Table S1. </b>Group average of fluorescence intensity values and the corresponding group average expressed as a ratio to the group average of the healthy control group measured in the protease activity assays with tape strip samples shown in Figure 3a-c. HC, healthy control; ILC, ichthyosis linearis circumflexa; SE, scaly erythroderma; L, lesional; NL, non-lesional; RFU, relative fluorescence units.<b>Supplementary Table S2. </b>Group average of fluorescence intensity values measured in the protease activity assays with squame samples shown in Figure 3d-f. ILC, ichthyosis linearis circumflexa; SE, scaly erythroderma; L, lesional; RFU, relative fluorescence units.<b>Supplementary Table S3. </b>Demographic and clinical characteristics of NS patients included in skin biopsy KLK expression analyses.<b>Supplementary Table S4. </b>Demographic and clinical characteristics of NS patients included in tape strip sample analyses.<b>Supplementary Table S5. </b>Demographic and clinical characteristics of NS patients included in skin squame sample analyses.<b>Supplementary Table S6. </b>Demographic characteristics of healthy controls included in tape strip sample analyses.<b>Supplementary Table S7. </b>Demographic characteristics of healthy controls included in skin biopsy analyses.<br><br>